Yuko Takazawa
Matsumoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Two Cases of BRAF V600K Melanoma With Recurrence During Adjuvant Dabrafenib Plus Trametinib Therapy.
Two Cases of BRAF V600K Melanoma With Recurrence During Adjuvant Dabrafenib Plus Trametinib Therapy.
Journal: The Journal of dermatology
Published: August 25, 2025
Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors
Journal: European journal of dermatology : EJD
Published: October 27, 2022
Late Onset of Cardiac Metastasis of a Melanoma following Nivolumab Immunotherapy.
Journal: Case reports in oncology
Published: February 02, 2022
Case of bullous pemphigoid following coronavirus disease 2019 vaccination.
Journal: The Journal of dermatology
Published: September 03, 2021
Successful treatment of cutaneous infection due to Purpureocillium lilacinum using voriconazole.
Journal: The Journal of dermatology
Published: April 30, 2020
5-Hydroxymethylcytosine as a putative marker for erosive adenomatosis of the nipple.
Journal: The Journal of dermatology
Published: December 26, 2015
Notch down-regulation in regenerated epidermis contributes to enhanced expression of interleukin-36α and suppression of keratinocyte differentiation during wound healing.
Journal: Journal of dermatological science
Published: December 30, 2014
Toll-like receptor 4 signaling promotes the migration of human melanoma cells.
Journal: The Tohoku journal of experimental medicine
Published: September 02, 2014
5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi.
Journal: Journal of dermatological science
Published: September 03, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026